1. Home
  2. TMCI vs ESPR Comparison

TMCI vs ESPR Comparison

Compare TMCI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • ESPR
  • Stock Information
  • Founded
  • TMCI 2014
  • ESPR 2008
  • Country
  • TMCI United States
  • ESPR United States
  • Employees
  • TMCI N/A
  • ESPR N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TMCI Health Care
  • ESPR Health Care
  • Exchange
  • TMCI Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • TMCI 449.2M
  • ESPR 445.6M
  • IPO Year
  • TMCI 2021
  • ESPR 2013
  • Fundamental
  • Price
  • TMCI $7.33
  • ESPR $2.76
  • Analyst Decision
  • TMCI Hold
  • ESPR Buy
  • Analyst Count
  • TMCI 5
  • ESPR 6
  • Target Price
  • TMCI $8.60
  • ESPR $6.50
  • AVG Volume (30 Days)
  • TMCI 343.4K
  • ESPR 6.1M
  • Earning Date
  • TMCI 11-04-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • TMCI N/A
  • ESPR N/A
  • EPS Growth
  • TMCI N/A
  • ESPR N/A
  • EPS
  • TMCI N/A
  • ESPR N/A
  • Revenue
  • TMCI $213,751,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • TMCI $10.63
  • ESPR $10.59
  • Revenue Next Year
  • TMCI $9.44
  • ESPR N/A
  • P/E Ratio
  • TMCI N/A
  • ESPR N/A
  • Revenue Growth
  • TMCI 7.67
  • ESPR N/A
  • 52 Week Low
  • TMCI $4.54
  • ESPR $0.69
  • 52 Week High
  • TMCI $10.79
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 58.53
  • ESPR 78.22
  • Support Level
  • TMCI $6.93
  • ESPR $2.37
  • Resistance Level
  • TMCI $7.48
  • ESPR $2.73
  • Average True Range (ATR)
  • TMCI 0.32
  • ESPR 0.17
  • MACD
  • TMCI -0.05
  • ESPR 0.02
  • Stochastic Oscillator
  • TMCI 49.70
  • ESPR 87.37

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: